Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice

European Journal of Pharmacology

Volumn 350, Issue 1, 1998, Pages 39-45

  Ukai, Makoto ^a   Shinkai, Norihiro ^a   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

(Mouse); Dopamine receptor; RU24213; SKF38393; Substance P; Tachykinin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; NEUROKININ A; SCOPOLAMINE; SENKTIDE; SUBSTANCE P; TACHYKININ;

ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; MOTOR DYSFUNCTION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMNESIA; ANIMALS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; MEMORY; MICE; NEUROKININ A; PEPTIDE FRAGMENTS; PHENETHYLAMINES; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SCOPOLAMINE; SUBSTANCE P; SULPIRIDE; TACHYKININS;

EID: 0032577597     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00231-3     Document Type: Article

References (20)

1. Alberch J., Arenas E., Perez-Navarro E., Marsal J. Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;445-449.
2. Arenas E., Pérez-Navarro E., Alberch J., Marsal J. Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum. Brain Res. 603:1993;317-320.
3. Boix P., Pfister M., Huston J.P., Schwarting R.K.W. Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: possible relevance for the central processing of reward and aversion. Behav. Brain Res. 63:1994;213-219.
4. Crawley J.N., Olschowka J.A., Diz D.I., Jacobowitz D.M. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides. 6:1985;891-901.
5. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
6. Hasenöhrl R.U., Huston J.P., Schuurman T. Neuropeptide substance P improves water maze performance in aged rats. Psychopharmacology. 101:1990;23-26.
7. Ichihara K., Nabeshima T., Kameyama T. Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol. Biochem. Behav. 30:1988;107-113.
8. 1 receptors. J. Pharmacol. Exp. Ther. 266:1993;557-562.
9. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmacol. 234:1993;9-15.
10. Itoh J., Ukai M., Kameyama T. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance. Eur. J. Pharmacol. 241:1993;99-104.
11. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21.
12. McGurk S.R., Levin E.D., Butcher L.L. Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav. Neural Biol. 46:1988;234-239.
13. Nakanishi Y. Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14:1991;123-136.
14. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: effects of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 29:1990;1111-1116.
15. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology. 94:1988;491-495.
16. Schlesinger K., Lipsitz D.U., Peck P.L., Pelleymounter M.A., Stewart J.M., Chase T.N. Substance P enhancement of passive and active avoidance conditioning in mice. Pharmacol. Biochem. Behav. 19:1983;655-661.
17. Stone W.S., Walser B., Gold S.D., Gold P.E. Scopolamine- and morphine-induced impairment of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 105:1991;264-271.
18. Ukai M., Shinkai N., Kameyama T. κ-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse. Eur. J. Pharmacol. 281:1995;173-178.
19. Ukai M., Shinkai N., Kameyama T. Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouse. Brain Res. 673:1995;335-338.
20. Ukai M., Shinkai N., Kameyama T. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice. Jpn. J. Psychopharmacol. 16:1996;97-101.